- Home
- LUCD vs MDBH Comparison
LUCD vs MDBH Comparison
Compare LUCD & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LUCD | MDBH |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.4M | 35.0M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | LUCD | MDBH |
|---|---|---|
| Price | $1.15 | $3.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.94 | N/A |
| AVG Volume (30 Days) | ★ 709.8K | 13.7K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $4,399,000.00 | $1,250,398.00 |
| Revenue This Year | $12.31 | N/A |
| Revenue Next Year | $152.14 | N/A |
| P/E Ratio | ★ N/A | $4.48 |
| Revenue Growth | ★ 5.01 | N/A |
| 52 Week Low | $0.75 | $3.16 |
| 52 Week High | $1.80 | $7.98 |
Technical Indicators
Market Signals| Indicator | LUCD | MDBH |
|---|---|---|
| Relative Strength Index (RSI) | 61.67 | 46.11 |
| Support Level | $1.02 | $3.25 |
| Resistance Level | $1.16 | $3.50 |
| Average True Range (ATR) | 0.05 | 0.21 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 100.00 | 29.03 |
Price Performance
Historical ComparisonAbout LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.